Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Wilde

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
British Journal of Haematology|November 1, 1996
A combined management protocol for patients with coagulation disorders infected with hepatitis C virusM M Ahmed, D J Mutimer, E Elias, et al.
Thrombosis and Haemostasis|November 1, 2001
Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleedingM P Smith, C A Ludlam, P W Collins, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 4, 2009
Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitorsP L F Giangrande, J T Wilde, B Madan, et al.
Journal of Virology|April 29, 1998
Epidemiology of infection with Epstein-Barr virus types 1 and 2: lessons from the study of a T-cell-immunocompromised hemophilic cohortQ Y Yao, D S Croom-Carter, R J Tierney, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 10, 2001
Guidelines on the diagnosis, management and prevention of hepatitis in haemophiliaM Makris, T Baglin, G Dusheiko, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
The rare coagulation disorders--review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' OrganisationP H B Bolton-Maggs, D J Perry, E A Chalmers, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 2011
The risk of variant Creutzfeldt-Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma productsS M A Zaman, F G H Hill, B Palmer, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
British Journal of Haematology|November 1, 1996
A combined management protocol for patients with coagulation disorders infected with hepatitis C virusM M Ahmed, D J Mutimer, E Elias, et al.
Thrombosis and Haemostasis|November 1, 2001
Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleedingM P Smith, C A Ludlam, P W Collins, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 4, 2009
Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitorsP L F Giangrande, J T Wilde, B Madan, et al.
Journal of Virology|April 29, 1998
Epidemiology of infection with Epstein-Barr virus types 1 and 2: lessons from the study of a T-cell-immunocompromised hemophilic cohortQ Y Yao, D S Croom-Carter, R J Tierney, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 10, 2001
Guidelines on the diagnosis, management and prevention of hepatitis in haemophiliaM Makris, T Baglin, G Dusheiko, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
The rare coagulation disorders--review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' OrganisationP H B Bolton-Maggs, D J Perry, E A Chalmers, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 2011
The risk of variant Creutzfeldt-Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma productsS M A Zaman, F G H Hill, B Palmer, et al.
Pageof 5